Hang Zhou
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Development and validation of a collagen score-based prediction model for neoadjuvant chemoimmunotherapy efficacy in locally advanced esophageal squamous cell carcinoma.
Journal: Journal of thoracic disease
Published: April 15, 2026
Prognosis and risk factors for pathological non-response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma.
Journal: Frontiers in immunology
Published: February 22, 2026
Prognostic Significance of the T12-SMI Before and After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: January 23, 2026
Percutaneous radiofrequency ablation of ground-glass nodules like lung cancer ~ 5-year follow-up.
Journal: Journal of cancer research and therapeutics
Published: August 24, 2025
METTL3-mediated m6A methylation of LncRNA DUXAP8 promoted esophageal squamous cell carcinoma progression by activating the PI3K/AKT signaling pathway.
Journal: Cell division
Published: July 30, 2025
CT imaging is a feasible method for the preoperative prediction of the main pathologic response after neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma.
Journal: Updates in surgery
Published: July 28, 2025
Single-cell and spatial transcriptome analyses reveal MAZ(+) NPC-like clusters as key role contributing to glioma recurrence and drug resistance.
Journal: Journal of translational medicine
Published: January 20, 2025
Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO).
Journal: Nature communications
Published: December 05, 2024
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.
Journal: Journal of translational medicine
Published: October 30, 2024
A-to-I-Edited miR-1304-3p Inhibits Glycolysis and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inactivating Wnt5a/ROR2 Signaling.
Journal: Molecular carcinogenesis
Published: September 14, 2024
Frequency and distribution pattern of lymph node metastasis after neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: August 29, 2024
The advantages of preoperative 3D reconstruction over 2D-CT in thoracoscopic segmentectomy.
Journal: Updates in surgery
Published: July 23, 2024
Last Updated: 09/26/2026